GeoVax (GOVX) director awarded 6,000 stock options at $1.18 strike

Rhea-AI Filing Summary

GeoVax Labs, Inc. director Robert T. McNally received a grant of stock options covering 6,000 shares of common stock. The options have a $1.18 per-share exercise price, become exercisable on June 17, 2027, and expire on June 17, 2036. Following this compensation-related award, his directly held derivative position from this grant totals 6,000 options, and the filing shows no open-market buying or selling activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCNALLY ROBERT T

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	6,000	$0.00	--

Holdings After Transaction: Stock Option — 6,000 shares (Direct, null)

Footnotes (1)

Key Figures

Options granted: 6,000 options Exercise price: $1.18 per share Exercisable date: June 17, 2027 +2 more

5 metrics

Options granted 6,000 options Stock option grant to director on June 17, 2026

Exercise price $1.18 per share Strike price of granted stock options

Exercisable date June 17, 2027 Date options become exercisable

Expiration date June 17, 2036 Option term end date

Derivative holdings after grant 6,000 options Total derivative securities following transaction

Key Terms

Stock Option, Common Stock, Grant, award, or other acquisition

3 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/22/2026 - 04:21 PM Accepted by SEC EDGAR 06/22/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCNALLY ROBERT T

(Last) (First) (Middle)

1955 LAKE PARK DRIVE

SUITE 300

(Street)

SMYRNA GEORGIA 30080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GeoVax Labs, Inc. [ GOVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1.18	06/17/2026		A		6,000		06/17/2027	06/17/2036	Common Stock	6,000	$0	6,000	D

Explanation of Responses:

	/s/ Robert T. McNally	06/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GeoVax (GOVX) disclose in this Form 4?

GeoVax disclosed that director Robert T. McNally received a grant of stock options for 6,000 shares of common stock. The options are a compensation award, not an open-market purchase or sale, and were issued with a fixed exercise price and long-term expiration date.

How many GeoVax (GOVX) stock options were granted to Robert T. McNally?

Robert T. McNally was granted stock options covering 6,000 shares of GeoVax common stock. These options give him the right to buy 6,000 shares at a preset exercise price, subject to the stated exercisability and expiration dates disclosed in the filing.

What is the exercise price and term of the new GeoVax (GOVX) options?

The granted GeoVax stock options have a $1.18 per-share exercise price and expire on June 17, 2036. They become exercisable on June 17, 2027, providing a long window during which the director can choose to convert the options into common shares.

Does this GeoVax (GOVX) Form 4 show any open-market buying or selling?

No, the Form 4 reports only a grant of stock options coded as a compensation-related acquisition. It does not show any open-market purchases or sales of GeoVax common stock by the director on the reported date, only this derivative award.

How did the GeoVax (GOVX) option grant change McNally’s reported holdings?

After the transaction, Robert T. McNally directly holds 6,000 stock options from this grant. The filing indicates total derivative securities following the transaction of 6,000 options, reflecting the newly awarded position associated with GeoVax common stock.